![Jeffrey Dayno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Dayno
Vorstandsvorsitzender bei
HARMONY BIOSCIENCES HOLDINGS, INC.
Vermögen: 460 270 $ am 31.07.2026
Profil
Jeffrey M.
Dayno is the founder of Delaware Valley Stroke Council.
Dr. Dayno is President, Chief Executive Officer & Director at Harmony Biosciences Holdings, Inc. since 2023.
Dr. Dayno is Director at Atrin Pharmaceuticals LLC since 2016.
Dr. Dayno is Director at Emalex Biosciences, Inc. Dr. Dayno was Senior Director-Medical Services at Merck & Co., Inc. Dr. Dayno was Medical Director at Jefferson Health Systems Stroke Center Network.
Dr. Dayno was Vice President-Medical Services at Cephalon LLC.
Dr. Dayno was Vice President-Global Medical Affairs at Shire ViroPharma, Inc. from 2011 to 2014.
Dr. Dayno was Chief Medical Officer at Labopharm, Inc. from 2010 to 2011.
Dr. Dayno was Chief Medical Officer at Zyla Life Sciences LLC from 2014 to 2017.
Dr. Dayno was President at Labopharm USA, Inc. Dr. Dayno was Vice President-Global Medical Affairs at Viropharma, Inc. from 2011 to 2014.
Dr. Dayno completed undergraduate studies at Trinity College (Connecticut).
Dr. Dayno earned a doctorate from Temple University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.03.2026 | 13.061 ( 0,02 % ) | 460 270 $ | 31.07.2026 |
Aktive Positionen von Jeffrey Dayno
| Unternehmen | Position | Beginn |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Vorstandsvorsitzender | 06.01.2023 |
Atrin Pharmaceuticals LLC
 Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Direktor/Vorstandsmitglied | 16.11.2016 |
Emalex Biosciences, Inc.
 Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system disorders | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jeffrey Dayno
| Unternehmen | Position | Ende |
|---|---|---|
| ZYLA LIFE SCIENCES | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2017 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 |
Viropharma, Inc. | Corporate Officer/Principal | 01.01.2014 |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2011 |
Delaware Valley Stroke Council
 Delaware Valley Stroke Council Medical/Nursing ServicesHealth Services The Delaware Valley Stroke Council works to reduce the incidence and impact of stroke through public awareness, education for both the public and professionals, legislative and patient advocacy, and by assisting individuals in accessing quality care regardless of background. The private company is based in Philadelphia. The organization helps stroke survivors and caregivers navigate health insurance systems to obtain necessary treatment, advocates for patients, collects and shares data to inform legislation, and collaborates with hospitals and rehabilitation centers to ensure access to advanced stroke care. The American company was founded by Jeffrey M. Dayno. | Gründer | - |
Ausbildung von Jeffrey Dayno
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Trinity College (Connecticut)
 Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Labopharm USA, Inc. | |
Jefferson Health Systems Stroke Center Network
 Jefferson Health Systems Stroke Center Network Packaged SoftwareTechnology Services Operates as healthcare systems | Technology Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Emalex Biosciences, Inc.
Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for central nervous system disorders | Health Technology |
Delaware Valley Stroke Council
Delaware Valley Stroke Council Medical/Nursing ServicesHealth Services The Delaware Valley Stroke Council works to reduce the incidence and impact of stroke through public awareness, education for both the public and professionals, legislative and patient advocacy, and by assisting individuals in accessing quality care regardless of background. The private company is based in Philadelphia. The organization helps stroke survivors and caregivers navigate health insurance systems to obtain necessary treatment, advocates for patients, collects and shares data to inform legislation, and collaborates with hospitals and rehabilitation centers to ensure access to advanced stroke care. The American company was founded by Jeffrey M. Dayno. | Health Services |
Viropharma, Inc. |
